Literature DB >> 17379961

Possibly simultaneous primary aldosteronism and preclinical Cushing's syndrome in a patient with double adenomas of right adrenal gland.

Takako Saito1, Aki Ikoma, Tomoyuki Saito, Hiroyuki Tamemoto, Yoshihisa Suminaga, Shigeki Yamada, Masanobu Kawakami, Takashi Suzuki, Hironobu Sasano, San-e Ishikawa.   

Abstract

We reported a rare case of simultaneous primary aldosteronism and preclinical Cushing's syndrome due to unilateral double adrenocortical adenomas in a 57 year-old woman who had had hypertension for the last 10 years. Abdominal computed tomography showed double tumors in her right adrenal gland. Physical findings revealed simple obesity and hypertension, but no other abnormal findings were detected. Laboratory findings demonstrated that serum potassium was 3.8 mmol/l; plasma renin activity, 0.3 ng/ml/h; plasma aldosterone, 100 pg/ml, and aldosterone renin ratio (ARR), 33. Serum cortisol was 15.7 microg/dl. There was no circadian rhythm of serum cortisol, and no suppression of serum cortisol in response to exogenous dexamethasone administration. Right adrenalectomy was performed under laparoscopy. Two well-circumscribed tumors, whose sizes were 21 and 19 mm in greatest diameter, were detected. They were macroscopically composed of a golden-yellow portion admixed with a brown portion, which corresponded to clear cells and compact cells, respectively. Immunohistochemical staining for steroidogenic enzymes demonstrated the presence of all the enzymes involved in corticosteroidogenesis in these two adenomas, indicating that the two adenomas produced both cortisol and mineralocorticoid. Specifically, one adenoma mainly caused excessive production of cortisol as compared to the other one. These findings indicate that overproduction of both cortisol and mineralocorticoid was evident in the two adenomas of the right adrenal gland in immunohistochemical study for steroidogenic enzymes, whereas there was less clinical manifestation of primary aldosteronism and Cushing's syndrome in the present patient.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17379961     DOI: 10.1507/endocrj.k06-180

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  4 in total

1.  The aldosterone to renin ratio in the evaluation of patients with incidentally detected adrenal masses.

Authors:  M Tzanela; G Effraimidis; G Effremidis; D Vassiliadi; A Szabo; N Gavalas; A Valatsou; E Botoula; N C Thalassinos
Journal:  Endocrine       Date:  2007-11-27       Impact factor: 3.633

2.  Difficult-to-control hypertension due to bilateral aldosterone-producing adrenocortical microadenomas associated with a cortisol-producing adrenal macroadenoma.

Authors:  R Morimoto; M Kudo; O Murakami; K Takase; S Ishidoya; Y Nakamura; T Ishibashi; S Takahashi; Y Arai; T Suzuki; H Sasano; S Ito; F Satoh
Journal:  J Hum Hypertens       Date:  2010-05-13       Impact factor: 3.012

3.  Benign adrenal adenomas secreting excess mineralocorticoids and glucocorticoids.

Authors:  Vivienne Yoon; Aliya Heyliger; Takashi Maekawa; Hironobu Sasano; Kelley Carrick; Stacey Woodruff; Jennifer Rabaglia; Richard J Auchus; Hans K Ghayee
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2013-09-23

4.  Adrenocortical hypofunction with simultaneous primary aldosteronism: A case report.

Authors:  Kaiyong Liang; Xiaojuan Ou; Xukai Huang; Qunfang Lan
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.